β Scribed by Jennifer H. Wilson-Welder; Maria P. Torres; Matt J. Kipper; Surya K. Mallapragada; Michael J. Wannemuehler; Balaji Narasimhan
No coin nor oath required. For personal study only.
For humans, companion animals, and food producing animals, vaccination has been touted as the most successful medical intervention for the prevention of disease in the twentieth century. However, vaccination is not without problems. With the development of new and less reactogenic vaccine antigens, which take advantage of molecular recombinant technologies, also comes the need for more effective adjuvants that will facilitate the induction of adaptive immune responses. Furthermore, current vaccine adjuvants are successful at generating humoral or antibody mediated protection but many diseases currently plaguing humans and animals, such as tuberculosis and malaria, require cell mediated immunity for adequate protection. A comprehensive discussion is presented of current vaccine adjuvants, their effects on the induction of immune responses, and vaccine adjuvants that have shown promise in recent literature.
π SIMILAR VOLUMES
## Abstract Increases in environmental problems linked to urbanization and increases in computational power are proposed as the main mechanisms behind positive feedbacks between experimental investigation and numerical modelling in mesoscale urban studies. The focus here is on the modelling, with a
## Abstract Alzheimer's disease (AD) is highly heritable, but genetically complex. Recently, three largeβscale genomeβwide association studies have made substantial breakthroughs in disentangling the genetic architecture of the disease. These studies combined include data from over 43β000 independe